Results out today confirm that the drug donanemab, hailed as a turning point in the fight against Alzheimer’s, slows cognitive decline by about a third.
The antibody treatment helps in the early stages of the disease.
It works in Alzheimer’s disease, not in other types of dementia, such as vascular dementia.
That is because it is designed to clear away one of the key features of Alzheimer’s disease – a substance called amyloid that builds up in the spaces between brain cells.
Please subscribe here: http://bit.ly/1rbfUog
#Dementia #Alzheimers #BBCNews
L'edizione della notte del Tg diretto da Enrico Mentana
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
NAPOLI (ITALPRESS) – Nessun problema per il Napoli di Antonio Conte, che batte 2-0 il Verona e ribadisce il primo…
The authorities in Los Angeles warn that scammers and looters are taking advantage of victims of the wildfires that have…
BOLOGNA (ITALPRESS) – La Roma acciuffa all’ultimo respiro il 2-2 al Dall’Ara contro il Bologna: dopo il vantaggio giallorosso di…
Subscribe here: http://bit.ly/1rbfUog For more news, analysis and features visit: www.bbc.com/news #BBCNews